Assessment of multi-wavelength pulse photometry for non-invasive dose estimation of circulating drugs and nanoparticles

Pratik Adhikari; Wakako Eklund; Eric A. Sherer; D. Patrick O'Neal

doi:10.1117/12.2213455

4 March 2016 Assessment of multi-wavelength pulse photometry for non-invasive dose estimation of circulating drugs and nanoparticles

Pratik Adhikari, Wakako Eklund, Eric A. Sherer, D. Patrick O'Neal

Author Affiliations +

Proceedings Volume 9715, Optical Diagnostics and Sensing XVI: Toward Point-of-Care Diagnostics; 97150O (2016) https://doi.org/10.1117/12.2213455
Event: SPIE BiOS, 2016, San Francisco, California, United States

Abstract

The feasibility of multi-wavelength photoplethysmography for the real-time sensing of absorptive and scattering agents in pulsatile blood is discussed. The use of pulsatile signals extracted from trans-illumination of an accessible section of tissue allows us to calculate the concentration of the optically extinctive species in the pulsatile blood. This technology, initially used for pulse oximetry and dye densitometry, can be applied to monitor in vivo concentration and clearance of various absorptive species. Recently, our prototype has been used monitor the concentration of therapeutic gold nanoparticles, antimalarial quinine, and the antifungal agent amphotericin B. The assessment of the optical properties, device specifications, and signal quality for each compound are presented. We observe that this technology can be used to monitor numerous extinctive drug and nano-materials that present features in the 350-1100 nm range. The rationale for using this technology in a clinical setting would be to improve outcomes by real-time pharmacological feedback and/or control at point of care in addition to the elimination of invasive blood draws for collection of data.

Conference Presentation

Citation Download Citation

Pratik Adhikari, Wakako Eklund, Eric A. Sherer, and D. Patrick O'Neal "Assessment of multi-wavelength pulse photometry for non-invasive dose estimation of circulating drugs and nanoparticles", Proc. SPIE 9715, Optical Diagnostics and Sensing XVI: Toward Point-of-Care Diagnostics, 97150O (4 March 2016); https://doi.org/10.1117/12.2213455

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available